Impact of the COVID-19 pandemic on prostate specific antigen testing and prostate cancer diagnosis in Ontario, Canada
Summary
Project ID: 2021-906/ TRIM 2022 0970 296 000
Principle Investigator: Robert Nam
Description: The aim of the current study is to compare prostate specific antigen (PSA) screening rates for prostate cancer before and during the pandemic. Among men diagnosed with prostate cancer, we will compare PSA levels at diagnosis, time from biopsy to definitive treatment, as well as prostate cancer grade and stage before versus during the pandemic. Among men who undergo biopsy, time from PSA to biopsy will be compared.
PIA approved: February 22, 2022
Status: In progress
Information
Project ID
2021-906/ TRIM 2022 0970 296 000